Scalp Cooling in MBC

NCT04986579 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Chemotherapy-induced Alopecia

Interventions

DEVICE: Paxman Scalp Cooling System
DRUG: Eribulin
DRUG: Sacituzumab govitecan
DRUG: Trastuzumab deruxtecan

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]